Latest studies
- Recruiting
Exploring the hidden burden of living with Glanzmann thrombasthenia
This study wants to hear from people living with Glanzmann thrombasthenia (GT) and their caregivers. We want to understand the daily challenges and feelings of those affected. Your stories can help improve support and understanding for everyone with GT.
Glanzmann thrombastheniaMonaco - Active not recruitingPHASE2
Study of the Impact of DPD Activity on the Efficacy of Capecitabine
This study looks at how a specific body process, called DPD activity, affects a breast cancer drug called capecitabine. We want to see if checking DPD levels before treatment helps us understand how well the drug will work for women with advanced breast cancer.
Breast Neoplasm Malignant FemaleMonaco - Recruiting
RETRO-PROSPECTIVE POSTMARKET CLINICAL STUDY FOR FX SHOULDER SOLUTIONS SHOULDER SYSTEMS
This study looks at how well shoulder replacements made by FX Shoulder Solutions work over 10 years. Researchers will check if people need more surgery, how much their shoulder moves, their pain, and any problems after the operation. It helps understand these devices in real life.
Humeral Fracture, ProximalGlenohumeral OsteoarthritisAvascular Necrosis of the Head of HumerusRotator Cuff TearMonaco - Recruiting
The "Global Paradise System" Registry
This study looks at a treatment called renal denervation using the Paradise Ultrasound system for high blood pressure. It tracks how well it works and if it's safe over time in people who have already had the treatment. It also checks blood pressure readings at home and quality of life.
HypertensionMonaco - RecruitingPHASE1
Phase I Trial of CArbonic Anhydrase Inhibition in Combination With Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma
This study is looking into a new use for an existing medicine called acetazolamide, in combination with standard treatments for small cell lung cancer. Researchers want to see if it can help improve how well chemotherapy and radiotherapy work by affecting how cancer cells get their energy.
Small Cell Lung CancerMonaco - Recruiting
Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1) to Exclude Lesions Linked to Significant Traumatic Brain Injuries
This study looks at whether a simple blood test can help emergency doctors decide if a brain scan (CT scan) is needed after a mild head injury, within 12 hours of it happening. Researchers are testing two substances in the blood, UCH-L1 and GFAP, to see if they can reliably show that there's no major brain injury.
Traumatic Brain InjuryMonaco - RecruitingPHASE3
Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis
This study looks at a new way to treat rheumatoid arthritis (RA) using two different medicines. It aims to see if starting with one medicine, then switching to another, works better for people whose current treatment isn't enough to control their RA.
Rheumatoid ArthritisMonaco - Active not recruiting
Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System
This study looks at how safe and effective a new treatment called FARAPULSE is for atrial fibrillation. It collects real-world information about people treated with this system in hospitals to see how well it works and if it improves their quality of life.
Atrial FibrillationMonaco - Active not recruiting
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
This study looks at how safe and effective a new treatment called FARAPULSE is for a heart condition called atrial fibrillation. It collects information for one year after the treatment. Doctors use the FARAPULSE system with special tools during the procedure.
Atrial FibrillationPulsed Field AblationFARAPULSEMonaco - Active not recruitingNA
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
This study looks at a treatment called renal denervation (RDN) for high blood pressure. It uses a device called Symplicity Spyral to see how well it works and if it's safe in the long term, especially for people whose blood pressure is hard to control.
HypertensionVascular DiseasesCardiovascular DiseasesChronic Kidney DiseasesMonaco